Cochrane Abstracts
Sublingual immunotherapy for allergic rhinitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sublingual Immunotherapy for Allergic Rhinitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436977/all/Sublingual_immunotherapy_for_allergic_rhinitis.
Sublingual immunotherapy for allergic rhinitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436977/all/Sublingual_immunotherapy_for_allergic_rhinitis. Accessed November 22, 2024.
Sublingual immunotherapy for allergic rhinitis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436977/all/Sublingual_immunotherapy_for_allergic_rhinitis
Sublingual Immunotherapy for Allergic Rhinitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436977/all/Sublingual_immunotherapy_for_allergic_rhinitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sublingual immunotherapy for allergic rhinitis
ID - 436977
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436977/all/Sublingual_immunotherapy_for_allergic_rhinitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
